Search for: "Par Pharmaceutical Companies, Inc" Results 41 - 60 of 90
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Feb 2013, 6:00 am by Rebecca Shafer, J.D.
Stack, CPA, Director of Operations, Amaxx Risk Solutions, Inc. is an expert in employer communication systems and part of the Amaxx team helping companies reduce their workers compensation costs by 20% to 50%. [read post]
15 Jan 2013, 11:33 am by Ed Silverman
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
19 Oct 2012, 6:13 pm by John W. Arden
The majority of the assets in these 18 markets would be divested to Par Pharmaceutical, Inc. [read post]
15 Apr 2012, 8:47 pm by Patent Docs
• Defendants: Par Pharmaceutical Companies Inc.; Par Pharmaceutical Inc. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
15 Sep 2011, 5:46 am by Ray Mullman
Attorney's office joined in the lawsuit, brought by Chicago pharmacist Bernard Lisitza in a 162-page complaint  Defendants include Par Pharmaceuticals Companies Inc. of Woodcliff Lake, N.J., and two foreign generic drugmakers overcharged the Medicaid program by getting pharmacies to dispense different, more-expensive, dosage forms than what was prescribed. [read post]
9 Sep 2011, 6:56 am by Ed Wallis
First, the AP (9/7, Johnson) reported Chicago pharmacist Bernard Lisitza is suing Par Pharmaceuticals Companies Inc., along with Australia’s Alphapharm PTY Ltd. and Canada’s Genpharm ULC, “in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines. [read post]
7 Sep 2011, 4:05 pm by mcarzima@imediainc.com
  The complaint alleges that Par Pharmaceuticals and two foreign companies - Alphapharm PTY Ltd. and Genpharm ULC - conspired with pharmacies to switch generic prescriptions to Par Pharmaceuticals’ generic version, allowing them to charge Medicaid higher prices. [read post]
7 Sep 2011, 4:22 am by Marie Louise
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US: Allergan files… [read post]
14 Aug 2011, 9:59 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:11-cv-00705; filed August 10, 2011 in the District Court of Delaware • Plaintiffs: Avanir Pharmaceuticals Inc.; Avanir Holding Company; Center for Neurologic Study • Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
6 Feb 2011, 9:34 pm by Patent Docs
• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
3 Jan 2011, 9:45 pm by Law Lady
Nursing Homes: PATIENTS SUFFER SUB-PAR CARE AT CALIFORNIA FACILITIES, CLASS ACTION SAYS, Valentine v. [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]